Price
$4.14
Increased by +0.98%
Dollar volume (20D)
4.46 M
ADR%
8.20
Earnings report date
May 21, 2025
Shares float
123.54 M
Shares short
3.82 M [3.09%]
Shares outstanding
224.34 M
Market cap
919.79 M
Beta
2.61
Price/earnings
8.54
20D range
2.68 5.00
50D range
2.37 5.00
200D range
2.21 5.28

CureVacN. V., a biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA).

It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202 which is in Phase 1 clinical trial for the treatment of rabies; and CVSQIV to treat multivalent seasonal influenza; Flu SV mRNA fot treating nucleotides, single antigen seasonal influenza.

The company develops CV8102, which is in Phase 1 clinical trial for treating melanoma and adenoidcystic carcinoma, as well as squamous cell cancer of skin, head, and neck; and CVGBM for treating cancer.

CureVacN. V. was founded in 2000 and is headquartered in Tübingen, Germany.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
Nov 12, 24 1.50
Increased by +781.82%
0.61
Increased by +145.90%
Aug 15, 24 -0.35
Decreased by -16.07%
-0.26
Decreased by -33.92%
Apr 25, 24 -0.39
Decreased by -44.44%
-0.18
Decreased by -116.67%
Mar 12, 24 -0.42
Increased by +36.36%
-0.20
Decreased by -110.00%
Nov 14, 23 -0.22
Increased by +12.00%
-0.23
Increased by +4.35%
Aug 17, 23 -0.30
Increased by +3.23%
-0.24
Decreased by -25.00%
May 30, 23 -0.27
Decreased by -237.50%
-0.34
Increased by +20.59%
Dec 31, 22 -0.66
Increased by +14.29%
-0.34
Decreased by -94.12%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Sep 30, 24 493.90 M
Increased by +2.90 K%
338.04 M
Increased by +794.40%
Increased by +68.44%
Increased by +123.17%
Jun 30, 24 14.44 M
Increased by +90.47%
-72.54 M
Decreased by -7.61%
Decreased by -502.51%
Increased by +43.50%
Mar 31, 24 12.37 M
Increased by +5.85%
-70.55 M
Increased by +45.22%
Decreased by -570.22%
Increased by +48.24%
Dec 31, 23 22.57 M
Increased by +93.06%
-86.65 M
Increased by +32.71%
Decreased by -383.98%
Increased by +65.15%
Sep 30, 23 16.48 M
Increased by +47.01%
-48.68 M
Decreased by -2.34%
Decreased by -295.34%
Increased by +30.39%
Jun 30, 23 7.58 M
Decreased by -62.38%
-67.41 M
Decreased by -17.07%
Decreased by -889.48%
Decreased by -211.19%
Mar 31, 23 11.69 M
Decreased by -71.65%
-128.78 M
Decreased by -6.55 K%
Decreased by -1.10 K%
Decreased by -23.36 K%
Dec 31, 22 11.69 M
Decreased by -71.65%
-128.78 M
Decreased by -6.55 K%
Decreased by -1.10 K%
Decreased by -23.36 K%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY